Janus Henderson Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,190,686
| Closed | -$149M | – | 2656 |
|
2022
Q3 | $149M | Sell |
2,190,686
-2,287,562
| -51% | -$156M | 0.06% | 283 |
|
2022
Q2 | $143M | Sell |
4,478,248
-1,125,007
| -20% | -$35.9M | 0.1% | 206 |
|
2022
Q1 | $194M | Buy |
5,603,255
+120,091
| +2% | +$4.16M | 0.09% | 209 |
|
2021
Q4 | $160M | Sell |
5,483,164
-789,518
| -13% | -$23.1M | 0.07% | 269 |
|
2021
Q3 | $160M | Buy |
6,272,682
+104,532
| +2% | +$2.66M | 0.07% | 271 |
|
2021
Q2 | $216M | Buy |
6,168,150
+285,575
| +5% | +$10M | 0.09% | 226 |
|
2021
Q1 | $240M | Sell |
5,882,575
-84,287
| -1% | -$3.43M | 0.11% | 200 |
|
2020
Q4 | $258M | Buy |
5,966,862
+540,580
| +10% | +$23.4M | 0.12% | 183 |
|
2020
Q3 | $299M | Buy |
5,426,282
+891,029
| +20% | +$49.1M | 0.16% | 149 |
|
2020
Q2 | $286M | Sell |
4,535,253
-18,728
| -0.4% | -$1.18M | 0.16% | 146 |
|
2020
Q1 | $233M | Buy |
4,553,981
+1,555,086
| +52% | +$79.4M | 0.16% | 145 |
|
2019
Q4 | $238M | Buy |
2,998,895
+549,524
| +22% | +$43.7M | 0.12% | 191 |
|
2019
Q3 | $119M | Buy |
2,449,371
+16,766
| +0.7% | +$813K | 0.06% | 318 |
|
2019
Q2 | $128M | Sell |
2,432,605
-83,760
| -3% | -$4.41M | 0.07% | 313 |
|
2019
Q1 | $133M | Sell |
2,516,365
-6,903
| -0.3% | -$365K | 0.07% | 309 |
|
2018
Q4 | $104M | Sell |
2,523,268
-744,770
| -23% | -$30.6M | 0.07% | 335 |
|
2018
Q3 | $124M | Sell |
3,268,038
-886,347
| -21% | -$33.7M | 0.07% | 338 |
|
2018
Q2 | $188M | Buy |
4,154,385
+452,843
| +12% | +$20.5M | 0.11% | 242 |
|
2018
Q1 | $179M | Buy |
3,701,542
+672,760
| +22% | +$32.5M | 0.11% | 237 |
|
2017
Q4 | $119M | Buy |
3,028,782
+1,613,224
| +114% | +$63.5M | 0.07% | 330 |
|
2017
Q3 | $44M | Buy |
1,415,558
+431,325
| +44% | +$13.4M | 0.03% | 552 |
|
2017
Q2 | $26.9M | Buy |
+984,233
| New | +$26.9M | 0.02% | 668 |
|